Schamberg‐like purpuric eruptions and tonsillitis in mild COVID ‐19

Abstract

A new beta-coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been identified as the cause of the pandemic coronavirus disease 19 (COVID-19). Children appear to be less affected by COVID-19 than adults by observed case rates in epidemiological studies. The majority of children have a mild disease and

Purpuric rash in a girl with a positive SARS-CoV-2 IgA result

“…Differential diagnosis includes druginduced rash and rashes due to other viral diseases. Wollina described Schamberg-like purpuric eruptions and tonsillitis in a 13-year-old female [2]. Similarly to our patient, she was in good health, with no fever or malaise.…”

The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – A systematic review of the literature

“… [ 276 ] Urticarial Vasculitis 1 F, 1 M 60 Prednisone, antihistamines [ 277 ] Schamberg's purpura F 13 N.A. [ 278 ] Chilblain-like lesions 13 F, 17 M 11 None [ 279 ] Maculopapular eruptions 2 M, 5 F 66.57 Glucocorticoids (6/7) [ 280 ] Retiform purpura F 79 N.A. [ 281 ] Pernio-like lesions 155 F, 163 M 25 N.A.…”

Autoimmune connective tissue diseases in the COVID-19 pandemic

“…78 One patient developed Schamberg's purpura. 79 A patient with proteinase 3-antineutrophil cytoplasmic antibody granulomatosis with polyangiitis on CS and rituximab who developed severe COVID-19 pneumonia was successfully treated with antivirals and HCQ. 80 Antineutrophil cytoplasmic antibody–positive polyangiitis treated with rituximab suggests that B-cell depletory therapy may not be a risk factor for severe forms and may even favor a milder course of COVID-19 disease.…”